0000899243-19-000283.txt : 20190103
0000899243-19-000283.hdr.sgml : 20190103
20190103162018
ACCESSION NUMBER: 0000899243-19-000283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190101
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Brien Stephanie Monaghan
CENTRAL INDEX KEY: 0001720907
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 19505695
MAIL ADDRESS:
STREET 1: C/O MORNINGSIDE TECHNOLOGY ADVISORY, LLC
STREET 2: 1188 CENTRE STREET
CITY: NEWTON CENTRE
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
BUSINESS PHONE: 502-241-4114
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-01
0
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001720907
O'Brien Stephanie Monaghan
C/O APELLIS PHARMACEUTICALS, INC.
6400 WESTWIND WAY, SUITE A
CRESTWOOD
KY
40014
1
0
0
0
Stock option (right to buy)
13.19
2019-01-01
4
A
0
17580
0.00
A
2028-12-31
Common Stock
17580
17580
D
This option was granted on January 1, 2019 and will vest in four equal quarterly installments on April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020, subject to continued service as a director.
/s/ David Watson, attorney-in-fact for Stephanie Monaghan O'Brien
2019-01-03